Post-stroke anxiety symptoms moderate the predictive efficacy of MIP1-α on acute ischemic stroke severity

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

BackgroundIschemic stroke (IS) elicits a robust neuroinflammatory response in which damage-associated molecular patterns (DAMPs) released from necrotic tissue drive systemic cytokine activation. Although macrophage inflammatory protein-1α (MIP-1α) is a recognized biomarker of stroke severity, its interaction with neuropsychiatric comorbidities, particularly Post-Stroke Anxiety symptoms (PSAS),…

Read original article on Frontiers in Psychiatry | New and Recent Articles →